Table 2.
The association between individual phthalate concentration and the prevalence of CVD.
| Variables | OR (95% CI) | p value | P for trend |
|---|---|---|---|
| MEP | |||
| T1 | Ref | ||
| T2 | 1.08 (0.61, 1.92) | 0.779 | |
| T3 | 0.98 (0.63, 1.54) | 0.944 | 0.915 |
| MEHHP | |||
| T1 | Ref | ||
| T2 | 0.70 (0.41, 1.20) | 0.192 | |
| T3 | 1.34 (0.77, 2.35) | 0.295 | 0.207 |
| MiBP | |||
| T1 | Ref | ||
| T2 | 1.59 (0.93, 2.75) | 0.092 | |
| T3 | 1.86 (1.08, 3.18) | 0.025 | 0.022 |
| MEOHP | |||
| T1 | Ref | ||
| T2 | 1.53 (0.89, 2.63) | 0.123 | |
| T3 | 1.67 (0.96, 2.91) | 0.068 | 0.076 |
| MBzP | |||
| T1 | Ref | ||
| T2 | 1.19 (0.65, 2.17) | 0.577 | |
| T3 | 1.32 (0.78, 2.25) | 0.295 | 0.293 |
| MCNP | |||
| T1 | Ref | ||
| T2 | 1.43 (0.89, 2.28) | 0.134 | |
| T3 | 1.85 (1.18, 2.91) | 0.008 | 0.011 |
| MCOP | |||
| T1 | Ref | ||
| T2 | 1.16 (0.65, 2.05) | 0.617 | |
| T3 | 1.39 (0.83, 2.35) | 0.210 | 0.205 |
| MECPP | |||
| T1 | Ref | ||
| T2 | 1.90 (1.10, 3.26) | 0.021 | |
| T3 | 2.22 (1.28, 3.86) | 0.005 | 0.008 |
| MBP | |||
| T1 | Ref | ||
| T2 | 1.20 (0.69, 2.10) | 0.504 | |
| T3 | 1.68 (1.02, 2.76) | 0.042 | 0.041 |
| MCPP | |||
| T1 | Ref | ||
| T2 | 0.82 (0.51, 1.32) | 0.414 | |
| T3 | 1.44 (0.93, 2.23) | 0.104 | 0.081 |
By comparing the second and third tertiles of each phthalate to the first, odds ratios (ORs) were calculated. The models were adjusted for age, gender, race/ethnicity, PIR, BMI, smoking status, hypertension, diabetes, total cholesterol, and eGFR.